Cancer treatment—residual (R) tumour indicator, yes/no code N
Data Element Attributes
Identifying and definitional attributes | |
Metadata item type: | Data Element |
---|---|
Short name: | Residual tumour indicator |
METEOR identifier: | 430267 |
Registration status: | Health!, Standard 08/05/2014 |
Definition: | An indicator of whether residual tumour is present after the course of treatment for cancer, as represented by a code. |
Data element concept attributes | |
Identifying and definitional attributes | |
Data element concept: | Cancer treatment—residual (R) tumour indicator |
---|---|
METEOR identifier: | 430253 |
Registration status: | Health!, Standard 08/05/2014 |
Definition: | An indicator of whether residual tumour is present or absent after the course of treatment for cancer. |
Object class: | Cancer treatment |
Property: | Residual (R) tumour indicator |
Value domain attributes | |
Identifying and definitional attributes | |
Value domain: | Yes/no code N |
---|---|
METEOR identifier: | 270732 |
Registration status: | Health!, Standard 01/03/2005 Community Services (retired), Standard 27/04/2007 Early Childhood, Standard 21/05/2010 Housing assistance, Standard 23/08/2010 Homelessness, Standard 23/08/2010 Independent Hospital Pricing Authority, Standard 01/11/2012 Indigenous, Standard 16/09/2014 Disability, Standard 07/10/2014 WA Health, Standard 19/03/2015 National Health Performance Authority (retired), Retired 01/07/2016 Tasmanian Health, Standard 27/05/2020 |
Definition: | A code set representing 'yes' and 'no'. |
Representational attributes | ||
Representation class: | Code | |
---|---|---|
Data type: | Boolean | |
Format: | N | |
Maximum character length: | 1 | |
Value | Meaning | |
Permissible values: | 1 | Yes |
2 | No |
Data element attributes | |
Collection and usage attributes | |
Guide for use: | Record the presence of residual tumour on completion of the course of treatment for cancer. In some cases treated with surgery and/or neoadjuvant therapy, residual tumour will be present at the primary site after treatment because of incomplete resection or local and regional disease extending beyond the scope of resection. |
---|---|
Collection methods: | This information should be sought from the patient's medical record, referral letters or attending medical clinician. |
Comments: | The presence of residual tumour may indicate the effect of treatment, influence further treatment decisions, and be a strong predictor of prognosis. |
Source and reference attributes | |
Submitting organisation: | Cancer Australia |
Reference documents: | American Joint Committee on Cancer 2010. AJCC Cancer Staging Manual, 7th edition. Springer: New York |
Relational attributes | |
Implementation in Data Set Specifications: | Gynaecological cancer (clinical) DSS Health!, Superseded 14/05/2015 Conditional obligation: This data element is to be recorded for patients with ovarian cancer and stage IV endometrial cancer when surgical treatment for gynaecological cancer has been completed. Gynaecological cancer (clinical) NBPDS Health!, Standard 14/05/2015 Conditional obligation: This data element is to be recorded for patients with ovarian cancer and stage IV endometrial cancer when surgical treatment for gynaecological cancer has been completed. Lung cancer (clinical) DSS Health!, Superseded 14/05/2015 Conditional obligation: Collect when a person with cancer has completed their initial course of cancer treatment. Lung cancer (clinical) NBPDS Health!, Standard 14/05/2015 Conditional obligation: Collect when a person with cancer has completed their initial course of cancer treatment. |